ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Diamedica Therapeutics (DMAC)

Technical Analysis Report for NASDAQ stock DMAC Diamedica Therapeutics. Dated: 23 Apr 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock DMAC Diamedica Therapeutics then click here. or read Experts views on Diamedica Therapeutics or Forecast & share price targets of Diamedica Therapeutics

Diamedica Therapeutics Opened at 6.46 and Closed at: 6.22, which is -4.02% of previous session's close. It moved within a range of 6.16 and 6.46
The session was a Bearish session with an average volume of 131200, which is -8.23% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.
  • Even though the stock has fallen, but its long term trend is positive and in an uptrend.

Support for tomorrow is 6.04 and resistance for tomorrow is 6.34
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 6.1, 5.98 resistance for tomorrow's hourly charts is 6.4, 6.58

10 Day SMA for Diamedica Therapeutics (DMAC) is 6.45 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Diamedica Therapeutics (DMAC) is 6.5 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Diamedica Therapeutics (DMAC) is 7.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 7.85 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Diamedica Therapeutics is 6.98 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Diamedica Therapeutics is at 6.5 and 200 DMA is at 6.98, while 50 DMA and 100 DMA are at 7.31 and 7.85 respectively

Diamedica Therapeutics (DMAC) moving average of 20 SMA is at 6.5 and 20 EMA is at 6.6

Diamedica Therapeutics (DMAC) moving average of 50 SMA is at 7.31 and 50 EMA is at 7.07

Diamedica Therapeutics (DMAC) moving average of 100 SMA is at 7.85 and 100 EMA is at 7.24

Diamedica Therapeutics (DMAC) moving average of 200 SMA is at 6.98 and 200 EMA is at 6.99

Utah Medical has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Utah Medical, about 17.62% more returns!

Urogen Pharma has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Urogen Pharma, about 45.01% more returns!

Diamedica Therapeutics has performed better than Insulet Corporation in short term. Holding Diamedica Therapeutics could be a better choice for now!

Phio Pharmaceuticals has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 6.05% more returns!

Petmed Express has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Petmed Express, about 5.74% more returns!

Outlook Therapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Outlook Therapeutics, about 47.3% more returns!

Lakeland Industries has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Lakeland Industries, about 39.33% more returns!

Krystal Biotech has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Krystal Biotech, about 15.82% more returns!

Iovance Biotherapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Iovance Biotherapeutics, about 3.51% more returns!

Diamedica Therapeutics has performed better than Esperion Therapeutics in short term. Holding Diamedica Therapeutics could be a better choice for now!

Assertio Therapeutics has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Assertio Therapeutics, about 1.47% more returns!

Apyx Medical has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Apyx Medical, about 8.16% more returns!

Apellis Pharmaceuticals has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Apellis Pharmaceuticals, about 141.29% more returns!

Amgen Inc has performed better than Diamedica Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 7.91% more returns!

Diamedica Therapeutics Technical analysis of indicators

Price action analysis of Diamedica Therapeutics (DMAC) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

ADX buy sell signal for Diamedica Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.

MACD generated a BUY signal for Diamedica Therapeutics in short term but the buy signal is initial and weak.

Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Diamedica Therapeutics in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 6.4 and Diamedica Therapeutics DMAC stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Diamedica Therapeutics DMAC stock. Volume based technical analysis of Diamedica Therapeutics DMAC stock is negative.

Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock DMAC Diamedica Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And DMAC Experts View which covers a lot of information including buying and selling signals

DMAC future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Diamedica Therapeutics or View Candle Stick Charts here

Chart Diamedica Therapeutics (DMAC)  Technical (Analysis) Reports Diamedica Therapeutics [

Videos related to: Diamedica Therapeutics (DMAC) Technical (Analysis) Reports Diamedica Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Diamedica Therapeutics (DMAC)  Technical (Analysis) Reports Diamedica Therapeutics [

 

Back to top